Valued at USD 6.56 billion in 2023, the North America continuous glucose monitoring market is poised for substantial growth. This market is projected to expand at an impressive CAGR of 14.5% during the forecast period from 2024 to 2032. By the end of 2032, the market is expected to reach a remarkable value of USD 23.22 billion.